Laurie Toich, Assistant Editor

A star-shaped delivery device could prevent medication adherence.

Patients who enrolled in a Health Leads program saw improvements in blood pressure and cholesterol levels.

Xtandi plus abiraterone acetate and prednisone fails to improve progression-free survival in prostate cancer.

Top news of the day from across the healthcare landscape.

Ceritinib (Zykadia) could potentially be used as a first-line treatment in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer.

Assistance program will provide financial assistance for FDA-approved HCV drugs.

The companies will develop the targeted antibody drug, MEDI1814 for Alzheimer’s disease.

Anesthetics and sedation drugs may pose cognitive risks in young children and pregnant women.

Some conditions associated with type 2 diabetes may significantly impair renal function.

Top news of the day from across the healthcare landscape.

Zykadia more than doubled progression-free survival in patients with ALK+ non-small cell lung cancer.

Celgene will continue trials with Abraxane plus immunotherapy drugs.

Celgene will continue trials with Abraxane plus immunotherapy drugs.

Inhibiting the SNAP23 protein could lead to increased insulin secretion.

Maci uses the patient’s own cartilage cells to replace damaged or defective cartilage tissue in the knee.

Top news of the day from across the healthcare landscape.

The combination drug Synjardy XR approved for use in patients with type 2 diabetes.

The combination drug Synjardy XR approved for use in patients with type 2 diabetes.

Switching Tasigna elicited a long-term response rate in patients with leukemia even after discontinuing treatment.

Switching from Glivec to Tasigna elicited a long-term response rate in patients with leukemia.

Lenalidomide (Revlimid) could potentially offer clinical benefits to patients with multiple myeloma.

Lenalidomide (Revlimid) could potentially offer clinical benefits to patients with multiple myeloma.

A newly created tool can diagnose cachexia in patients with cancer and other diseases.

John Campo, vice president of Pharmacy Trade Relations and Contracting at Managed Health Care Associates discusses how to improve the relationship between specialty pharmacies and specialty drug manufacturers.

Top news of the day from across the healthcare landscape.

Pioglitazone may increase a patient’s risk of developing bladder cancer.

Pioglitazone may increase a patient’s risk of developing bladder cancer.

Results from an interim analysis show ritixumab biosimilar to be equivalent to reference product.

Modified kidney cells could potentially regulate insulin for 3 weeks in patients with diabetes.

A new study examines a different treatment strategy for pneumonia.